200
Views
8
CrossRef citations to date
0
Altmetric
Original

Rituximab-CHOP-ESHAP vs CHOP-ESHAP-high-dose therapy vs conventional CHOP chemotherapy in high-intermediate and high-risk aggressive non-Hodgkin's lymphoma

, MD, MSc, , &
Pages 1306-1314 | Received 29 May 2005, Accepted 21 Nov 2005, Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Gangjian Wang, Yu Chang, Xiaolong Wu, Xin Li, Ling Li, Lei Zhang, Xiaorui Fu, Zhenchang Sun, Xudong Zhang & Mingzh Zhang. (2019) Clinical features and prognostic factors of primary bone marrow lymphoma. Cancer Management and Research 11, pages 2553-2563.
Read now
Frida Kasteng, Martin Erlanson, Hans Hagberg, Eva Kimby, Thomas Relander & Jonas Lundkvist. (2008) Cost-effectiveness of maintenance rituximab treatment after second line therapy in patients with follicular lymphoma in Sweden. Acta Oncologica 47:6, pages 1029-1036.
Read now

Articles from other publishers (6)

Narges Seyfizadeh, Nayer Seyfizadeh, Justin Hasenkamp & Sara Huerta-Yepez. (2016) A molecular perspective on rituximab: A monoclonal antibody for B cell non Hodgkin lymphoma and other affections. Critical Reviews in Oncology/Hematology 97, pages 275-290.
Crossref
Maurizio Martelli, Andrés J.M. Ferreri, Claudio Agostinelli, Alice Di Rocco, Michael Pfreundschuh & Stefano A. Pileri. (2013) Diffuse large B-cell lymphoma. Critical Reviews in Oncology/Hematology 87:2, pages 146-171.
Crossref
Markus Schaaf, Marcel Reiser, Peter Borchmann, Andreas Engert & Nicole Skoetz. (2012) High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults. Cochrane Database of Systematic Reviews.
Crossref
Alessandra Tucci, Samantha Ferrari, Chiara Bottelli, Erika Borlenghi, Monica Drera & Giuseppe Rossi. (2009) A comprehensive geriatric assessment is more effective than clinical judgment to identify elderly diffuse large cell lymphoma patients who benefit from aggressive therapy. Cancer 115:19, pages 4547-4553.
Crossref
. (2007) Current Awareness in Hematological Oncology. Hematological Oncology 25:2, pages 98-105.
Crossref
Michael Wenger. 2007. Handbook of Therapeutic Antibodies. Handbook of Therapeutic Antibodies 1033 1108 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.